Diaceutics Partners With Global EQA Providers to Implement Best-in-class Testing Standards
(WorldNews Health)

PARSIPPANY, New Jersey--(BUSINESS WIRE)--Sep 28, 2020-- Diaceutics PLC, (AIM: DXRX), today announces three new partnerships on its DXRX platform, as it continues with its mission to get every patient the treatment they deserve. The company has signed agreements with external quality assessment (EQA) organizations Canadian Pathology Quality Assurance – Assurance Qualit&eaigu; Canadienne en Pathologie (CPQA-AQCP), European Molecular Genetics Quality Network (EMQN CIC) and Nordic Immunohistochemical Quality Control (NordiQC). The partnerships will help to establish best-in-class global laboratory standards for diagnostic testing through in-lab quality assurance and will provide the transparency which...